Wan Hsi Chen

Wan Hsi Chen

Auto-generated profile, based on publicly available information

Wan Hsi Chen

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2024 in Science Advances
Verified
Journal Article
Open access
SWSung-Jen Wei
Sung-Jen Wei
JSJoseph R. Schell
Joseph R. Schell
ECE. Sandra Chocron
E. Sandra Chocron
MVMahboubeh Varmazyad
Mahboubeh Varmazyad
GXGuogang Xu
Guogang Xu
David R GiusDavid R Gius
David R Gius
A ketogenic diet (KD) is a high-fat, low-carbohydrate diet that leads to the generation of ketones. While KDs improve certain health conditions and are popular for weight loss, detrimental effects have also been reported. Here, we show mice on two different KDs and, at different ages, induce cellular senescence in multiple organs, including the heart and kidney. This effect is mediated through adenosine monophosphate–activated protein kinase (AMPK) and inactivation of mouse double minute 2 (MDM2) by caspase-2, leading to p53 accumulation and p21 induction. This was established using p53 and caspase-2 knockout mice and inhibitors to AMPK, p21, and caspase-2. In addition, senescence-associated secretory phenotype biomarkers were elevated in serum from mice on a KD and in plasma samples from patients on a KD clinical trial. Cellular senescence was eliminated by a senolytic and prevented by an intermittent KD. These results have important clinical implications, suggesting that the effects of a KD are contextual and likely require individual optimization.

18 August 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
BKBalakrishna Koneru
Balakrishna Koneru
AFAhsan Farooqi
Ahsan Farooqi
TNThinh Nguyen
Thinh Nguyen
WCWan Hsi Chen
Wan Hsi Chen
AHAshly Hindle
Ashly Hindle
CRC. Patrick Reynolds
C. Patrick Reynolds
ATM activation at telomeres confers chemoresistance in ALT neuroblastoma and is reversible in preclinical models by ATM knockdown or inhibition.

4 September 2019 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
TNThinh Nguyen
Thinh Nguyen
BKBalakrishna Koneru
Balakrishna Koneru
SWSung-Jen Wei
Sung-Jen Wei
WCWan Hsi Chen
Wan Hsi Chen
MMMonish Makena
Monish Makena
CRC. Patrick Reynolds
C. Patrick Reynolds
Recurrent high-risk neuroblastoma is a childhood cancer that often fails to respond to therapy. Fenretinide (4-HPR) is a cytotoxic retinoid with clinical activity in recurrent neuroblastoma and venetoclax (ABT-199) is a selective inhibitor of the antiapoptotic protein B-cell lymphoma-2 (BCL-2). We evaluated activity of 4-HPR + ABT-199 in preclinical models of neuroblastoma. Patient-derived cell lines and xenografts from progressive neuroblastoma were tested. Cytotoxicity was evaluated by DIMSCAN, apoptosis by flow cytometry, and gene expression by RNA sequencing, quantitative RT-PCR, and immunoblotting. 4-HPR + ABT-199 was highly synergistic against high BCL-2–expressing neuroblastoma cell lines and significantly improved event-free survival of mice carrying high BCL-2–expressing patient-derived xenografts (PDX). In 10 matched-pair cell lines [established at diagnosis (DX) and progressive disease (PD) from the same patients], BCL-2 expression in the DX and PD lines was comparable, suggesting that BCL-2 expression at diagnosis may provide a biomarker for neuroblastomas likely to respond to 4-HPR + ABT-199. In a pair of DX (COG-N-603x) and PD (COG-N-623x) PDXs established from the same patient, COG-N-623x was less responsive to cyclophosphamide + topotecan than COG-N-603x, but both DX and PD PDXs were responsive to 4-HPR + ABT-199. Synergy of 4-HPR + ABT-199 was mediated by induction of NOXA via 4-HPR stimulation of reactive oxygen species that induced expression of ATF4 and ATF3, transcription factors for NOXA. Thus, fenretinide + venetoclax is a synergistic combination that warrants clinical testing in high BCL-2–expressing neuroblastoma.

8 January 2025 in Journal of Biological Rhythms
Verified
Journal Article
Open access
QZQing Zhang
Qing Zhang
CLChristopher Litwin
Christopher Litwin
KDKristi Dietert
Kristi Dietert
ITIoannis Tsialtas
Ioannis Tsialtas
WCWan Hsi Chen
Wan Hsi Chen
KKKevin B. Koronowski
Kevin B. Koronowski
Circadian disruption is pervasive in modern society and associated with increased risk of disease. Chronic jet lag paradigms are popular experimental tools aiming to emulate human circadian disruption experienced during rotating and night shift work. Chronic jet lag induces metabolic phenotypes tied to liver and systemic functions, yet lack of a clear definition for how rhythmic physiology is impaired under these conditions hinders the ability to identify the underlying molecular mechanisms. Here, we compared 2 common chronic jet lag paradigms and found that neither induced arrythmicity of the liver and each had distinct effects on rhythmicity. Instead, more frequent 8-h forward shifts of the light schedule induced more severe misalignment and non-fasted hyperglycemia. Every other day shifts eventually uncoupled behavioral and hepatic rhythms from the light cycle, reminiscent of free-running conditions. These results point to misalignment, not arrhythmicity, as the initial disturbance tied to metabolic dysfunction in environmental circadian disruption and highlight considerations for the interpretation and design of chronic jet lag studies.


3 April 2023
Verified
Other
Open access
TNThinh H. Nguyen
Thinh H. Nguyen
BKBalakrishna Koneru
Balakrishna Koneru
SWSung-Jen Wei
Sung-Jen Wei
WCWan Hsi Chen
Wan Hsi Chen
MMMonish Makena
Monish Makena
CRC. Patrick Reynolds
C. Patrick Reynolds